Eisai Company, Ltd. Receives Approval to Market Insomnia Treatment Lunesta in Japan

Published: Jan 19, 2012

Tokyo, Jan 18, 2012 (JCN Newswire) - Eisai Co. Ltd announced today that it received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) on January 18, 2012 to market Lunesta (eszopiclone), a product the company has been developing in Japan, as a treatment for insomnia.

Back to news